{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:47:01Z","timestamp":1789681621470,"version":"4.0.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100016989","name":"Korea University Medicine","doi-asserted-by":"publisher","award":["K2125941"],"award-info":[{"award-number":["K2125941"]}],"id":[{"id":"10.13039\/100016989","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2022R1F1A1072767"],"award-info":[{"award-number":["NRF-2022R1F1A1072767"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>This study aimed to compare the levels of various growth factors in maternal serum and umbilical vein serum between individuals with preeclampsia (PE) and those with normotensive pregnancies. One hundred eight pregnant women were enrolled in this prospective study. Blood samples were taken at third trimester. 67 serum samples of preeclampsia and 41 normotensive mothers were collected. Umbilical vein serum samples of 27 preeclampsia and 38 normotensive pregnancies were collected. Serum levels of BDNF, EGF, FGF-2, HGF, LIF, NGF-beta, PDGF-BB, PlGF-1, SCF, and vascular endothelial growth factor (VEGF)-A and D were measured. EGF, HGF, LIF, and SCF levels were significantly higher in PE compared to normotensive group after adjustment for gestational age. There were no differences in growth factors in umbilical vein serum between two groups. EGF, NGF-beta and SCF were associated with the elevation of systolic and diastolic blood pressure. SCF showed a positive correlation with ALT and creatinine and a decreasing trend as gestational age advances. The ROC curve revealed cutoff value of 36.6 pg\/mL in EGF, 23.5 in HGF, 2.78 in LIF and 2.95 in SCF (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001, <jats:italic>p<\/jats:italic>\u2009=\u20090.042, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Circulating growth factors in PE may be responsible for development or consequence associated with the pathogenesis in PE especially elevated EGF, HGF, LIF and SCF.<\/jats:p>","DOI":"10.1038\/s41598-025-15314-z","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:45:50Z","timestamp":1758883550000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Diagnostic applicability of the circulating growth factors in preeclampsia"],"prefix":"10.1038","volume":"15","author":[{"given":"Ho Yeon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seoyoung","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwan Heup","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Joong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"issue":"12","key":"15314_CR1","doi-asserted-by":"publisher","first-page":"101203","DOI":"10.1016\/j.ajogmf.2023.101203","volume":"5","author":"S Yagel","year":"2023","unstructured":"Yagel, S. et al. Expert review: Preeclampsia type I and type II. Am. J. Obstet. Gynecol. MFM. 5 (12), 101203 (2023).","journal-title":"Am. J. Obstet. Gynecol. MFM"},{"issue":"1","key":"15314_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1414838","volume":"374","author":"H Zeisler","year":"2016","unstructured":"Zeisler, H. et al. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Engl. J. Med. 374 (1), 13\u201322 (2016).","journal-title":"N Engl. J. Med."},{"issue":"2","key":"15314_CR3","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/uog.26032","volume":"61","author":"H Stepan","year":"2023","unstructured":"Stepan, H. et al. Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction. Ultrasound Obstet. Gynecol. 61 (2), 168\u2013180 (2023).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"15314_CR4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.preghy.2022.06.008","volume":"29","author":"MS Tanner","year":"2022","unstructured":"Tanner, M. S. et al. The effect of comorbidities on the sFLT-1:PlGF ratio in preeclampsia. Pregnancy Hypertens. 29, 98\u2013100 (2022).","journal-title":"Pregnancy Hypertens."},{"issue":"3","key":"15314_CR5","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ajog.2023.03.032","volume":"229","author":"P Chaemsaithong","year":"2023","unstructured":"Chaemsaithong, P. et al. Accuracy of placental growth factor alone or in combination with soluble fms-like tyrosine kinase-1 or maternal factors in detecting preeclampsia in asymptomatic women in the second and third trimesters: A systematic review and meta-analysis. Am. J. Obstet. Gynecol. 229 (3), 222\u2013247 (2023).","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"15314_CR6","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1055\/s-0029-1224141","volume":"213","author":"F Herr","year":"2009","unstructured":"Herr, F., Baal, N. & Zygmunt, M. Studies of placental vasculogenesis: A way to understand pregnancy pathology? Z. Geburtshilfe Neonatol. 213 (3), 96\u2013100 (2009).","journal-title":"Z. Geburtshilfe Neonatol"},{"issue":"14","key":"15314_CR7","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1161\/CIRCULATIONAHA.104.526954","volume":"112","author":"E Toyota","year":"2005","unstructured":"Toyota, E. et al. Vascular endothelial growth factor is required for coronary collateral growth in the rat. Circulation 112 (14), 2108\u20132113 (2005).","journal-title":"Circulation"},{"key":"15314_CR8","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.cca.2016.11.034","volume":"464","author":"LO Perucci","year":"2017","unstructured":"Perucci, L. O. et al. Decreased plasma concentrations of brain-derived neurotrophic factor in preeclampsia. Clin. Chim. Acta. 464, 142\u2013147 (2017).","journal-title":"Clin. Chim. Acta"},{"key":"15314_CR9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ijdevneu.2014.06.008","volume":"37","author":"V D\u2019Souza","year":"2014","unstructured":"D\u2019Souza, V. et al. Levels of brain derived neurotrophic factors across gestation in women with preeclampsia. Int. J. Dev. Neurosci. 37, 36\u201340 (2014).","journal-title":"Int. J. Dev. Neurosci."},{"issue":"6","key":"15314_CR10","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S0015-0282(01)02878-3","volume":"76","author":"A Lass","year":"2001","unstructured":"Lass, A. et al. Leukemia inhibitory factor in human reproduction. Fertil. Steril. 76 (6), 1091\u20131096 (2001).","journal-title":"Fertil. Steril."},{"key":"15314_CR11","doi-asserted-by":"publisher","first-page":"930582","DOI":"10.3389\/fimmu.2022.930582","volume":"13","author":"X Lan","year":"2022","unstructured":"Lan, X. et al. First-Trimester serum cytokine profile in pregnancies conceived after assisted reproductive technology (ART) with subsequent Pregnancy-Induced hypertension. Front. Immunol. 13, 930582 (2022).","journal-title":"Front. Immunol."},{"issue":"4","key":"15314_CR12","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1053\/plac.2001.0783","volume":"23","author":"S Smith","year":"2002","unstructured":"Smith, S. et al. Growth factor rescue of cytokine mediated trophoblast apoptosis. Placenta 23 (4), 322\u2013330 (2002).","journal-title":"Placenta"},{"issue":"11","key":"15314_CR13","first-page":"4092","volume":"84","author":"SW Kauma","year":"1999","unstructured":"Kauma, S. W., Bae-Jump, V. & Walsh, S. W. Hepatocyte growth factor stimulates trophoblast invasion: A potential mechanism for abnormal placentation in preeclampsia. J. Clin. Endocrinol. Metab. 84 (11), 4092\u20134096 (1999).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"15314_CR14","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/JTO.0b013e3182398e69","volume":"7","author":"T Yamada","year":"2012","unstructured":"Yamada, T. et al. Hepatocyte growth factor induces resistance to anti-epidermal growth factor receptor antibody in lung cancer. J. Thorac. Oncol. 7 (2), 272\u2013280 (2012).","journal-title":"J. Thorac. Oncol."},{"issue":"8","key":"15314_CR15","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/s41372-018-0112-0","volume":"38","author":"LL Jelliffe-Pawlowski","year":"2018","unstructured":"Jelliffe-Pawlowski, L. L. et al. Prediction of preterm birth with and without preeclampsia using mid-pregnancy immune and growth-related molecular factors and maternal characteristics. J. Perinatol. 38 (8), 963\u2013972 (2018).","journal-title":"J. Perinatol."},{"issue":"9","key":"15314_CR16","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1016\/j.bbamcr.2007.05.006","volume":"1773","author":"HJ Park","year":"2007","unstructured":"Park, H. J. et al. Up-regulation of VEGF expression by NGF that enhances reparative angiogenesis during thymic regeneration in adult rat. Biochim. Biophys. Acta. 1773 (9), 1462\u20131472 (2007).","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"15314_CR17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.mvr.2007.07.004","volume":"75","author":"B Nico","year":"2008","unstructured":"Nico, B. et al. Nerve growth factor as an angiogenic factor. Microvasc Res. 75 (2), 135\u2013141 (2008).","journal-title":"Microvasc Res."},{"issue":"2","key":"15314_CR18","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1530\/REP-14-0112","volume":"148","author":"P Frank","year":"2014","unstructured":"Frank, P. et al. Balanced levels of nerve growth factor are required for normal pregnancy progression. Reproduction 148 (2), 179\u2013189 (2014).","journal-title":"Reproduction"},{"key":"15314_CR19","doi-asserted-by":"crossref","unstructured":"ACOG practice bulletin 222: Gestational hypertension and preeclampsia. Obstet. Gynecol. 135(6), e237\u2013e260 (2020).","DOI":"10.1097\/AOG.0000000000003891"},{"issue":"2","key":"15314_CR20","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.cyto.2013.03.002","volume":"62","author":"M Wu","year":"2013","unstructured":"Wu, M. et al. The low expression of leukemia inhibitory factor in endometrium: Possible relevant to unexplained infertility with multiple implantation failures. Cytokine 62 (2), 334\u2013339 (2013).","journal-title":"Cytokine"},{"issue":"4","key":"15314_CR21","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s10735-021-09989-7","volume":"52","author":"M Abdolalian","year":"2021","unstructured":"Abdolalian, M. et al. The role of leukemia inhibitory factor in pathogenesis of pre-eclampsia: Molecular and cell signaling approach. J. Mol. Histol. 52 (4), 635\u2013642 (2021).","journal-title":"J. Mol. Histol."},{"issue":"3","key":"15314_CR22","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.placenta.2014.12.006","volume":"36","author":"DR Armant","year":"2015","unstructured":"Armant, D. R. et al. Reduced expression of the epidermal growth factor signaling system in preeclampsia. Placenta 36 (3), 270\u2013278 (2015).","journal-title":"Placenta"},{"key":"15314_CR23","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1038\/srep02407","volume":"3","author":"R Moslehi","year":"2013","unstructured":"Moslehi, R. et al. Integrative transcriptome analysis reveals dysregulation of canonical cancer molecular pathways in placenta leading to preeclampsia. Sci. Rep. 3, 2407 (2013).","journal-title":"Sci. Rep."},{"key":"15314_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejogrb.2019.05.036","volume":"240","author":"K Kupsamy","year":"2019","unstructured":"Kupsamy, K., Moodley, J. & Naicker, T. Hepatocyte growth factor and epidermal growth factor in HIV infected women with preeclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol. 240, 9\u201314 (2019).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"15314_CR25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.placenta.2021.08.002","volume":"114","author":"CA Whigham","year":"2021","unstructured":"Whigham, C. A. et al. Placental growth factor is negatively regulated by epidermal growth factor receptor (EGFR) signaling. Placenta 114, 22\u201328 (2021).","journal-title":"Placenta"},{"issue":"4","key":"15314_CR26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ajog.2008.01.009","volume":"198","author":"RE Leach","year":"2008","unstructured":"Leach, R. E. et al. Diminished survival of human cytotrophoblast cells exposed to hypoxia\/reoxygenation injury and associated reduction of heparin-binding epidermal growth factor-like growth factor. Am. J. Obstet. Gynecol. 198 (4), 471 (2008).","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"5","key":"15314_CR27","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1111\/jog.12362","volume":"40","author":"T Chenthuran","year":"2014","unstructured":"Chenthuran, T. et al. Polymorphism in the epidermal growth factor gene is associated with pre-eclampsia and low birthweight. J. Obstet. Gynaecol. Res. 40 (5), 1235\u20131242 (2014).","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"15314_CR28","doi-asserted-by":"crossref","unstructured":"Clemente, L. & Bird, I. M. The epidermal growth factor receptor in healthy pregnancy and preeclampsia. J. Mol. Endocrinol. 70(1), e220105 (2023).","DOI":"10.1530\/JME-22-0105"},{"issue":"1","key":"15314_CR29","doi-asserted-by":"publisher","first-page":"F12","DOI":"10.1152\/ajprenal.00112.2013","volume":"305","author":"A Staruschenko","year":"2013","unstructured":"Staruschenko, A. et al. Epidermal growth factors in the kidney and relationship to hypertension. Am. J. Physiol. Ren. Physiol. 305 (1), F12\u201320 (2013).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"1","key":"15314_CR30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1159\/000527212","volume":"213","author":"Z Liu","year":"2024","unstructured":"Liu, Z. et al. Hepatocyte growth factor promotes differentiation potential and stress response of human stem cells from apical papilla. Cells Tissues Organs. 213 (1), 40\u201354 (2024).","journal-title":"Cells Tissues Organs."},{"issue":"1","key":"15314_CR31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/10641955.2017.1411946","volume":"37","author":"ML Martinez-Fierro","year":"2018","unstructured":"Martinez-Fierro, M. L. et al. Early pregnancy protein multiplex screening reflects Circulating and urinary divergences associated with the development of preeclampsia. Hypertens. Pregnancy. 37 (1), 37\u201350 (2018).","journal-title":"Hypertens. Pregnancy"},{"issue":"Pt B","key":"15314_CR32","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.ijdevneu.2015.08.003","volume":"47","author":"V D\u2019Souza","year":"2015","unstructured":"D\u2019Souza, V. et al. Maternal nerve growth factor levels during pregnancy in women with preeclampsia: A longitudinal study. Int. J. Dev. Neurosci. 47 (Pt B), 340\u2013346 (2015).","journal-title":"Int. J. Dev. Neurosci."},{"issue":"8","key":"15314_CR33","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.placenta.2015.06.006","volume":"36","author":"AS Sahay","year":"2015","unstructured":"Sahay, A. S. et al. Neurotrophin levels in different regions of the placenta and their association with birth outcome and blood pressure. Placenta 36 (8), 938\u2013943 (2015).","journal-title":"Placenta"},{"issue":"1","key":"15314_CR34","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10517-019-04670-2","volume":"168","author":"YA Romanov","year":"2019","unstructured":"Romanov, Y. A. et al. Human umbilical cord blood serum\/plasma: Cytokine profile and prospective application in regenerative medicine. Bull. Exp. Biol. Med. 168 (1), 173\u2013177 (2019).","journal-title":"Bull. Exp. Biol. Med."},{"key":"15314_CR35","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.ijcard.2015.10.110","volume":"203","author":"SW Kim","year":"2016","unstructured":"Kim, S. W. et al. Therapeutic effects of late outgrowth endothelial progenitor cells or mesenchymal stem cells derived from human umbilical cord blood on infarct repair. Int. J. Cardiol. 203, 498\u2013507 (2016).","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"15314_CR36","doi-asserted-by":"publisher","first-page":"12262","DOI":"10.1038\/s41598-023-39313-0","volume":"13","author":"HY Cho","year":"2023","unstructured":"Cho, H. Y. et al. Prospective epigenome and transcriptome analyses of cord and peripheral blood from preterm infants at risk of bronchopulmonary dysplasia. Sci. Rep. 13 (1), 12262 (2023).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15314-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15314-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15314-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:45:53Z","timestamp":1758883553000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15314-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15314"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-15314-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"23 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32963"}}